Skip to the page

Data / Drug companies / Esteve Quimica SA

Esteve Quimica SA: 18 products in the FDA NDC directory, labeler code 57572

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Esteve Quimica SA (labeler code 57572) lists 18 products in the FDA National Drug Code Directory. By type: 18 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 25, 2025.

The request: Watch Esteve Quimica SA (FDA labeler code 57572): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
57572
Products in commercial distribution
18
Packages
19
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
September 28, 2007
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients18100%

Products by type

TypeProductsShare
Bulk ingredients18100%

Dosage forms

Dosage formProductsShare
Powder18100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Zanubrutinib57572-0729PowderBulk ingredientsSeptember 25, 2025
Bictegravir sodium57572-0728PowderBulk ingredientsFebruary 13, 2025
Xanomeline tartrate57572-0727PowderBulk ingredientsNovember 25, 2024
Voxelotor57572-0726PowderBulk ingredientsJuly 3, 2024
Vx-12157572-0725PowderBulk ingredientsApril 19, 2024
Tucatinib57572-0723PowderBulk ingredientsMay 5, 2023
Vx-56157572-0722PowderBulk ingredientsDecember 12, 2022
Cyclopentolate hcl57572-0721PowderBulk ingredientsMay 12, 2022
Nirmaltrelvir57572-0720PowderBulk ingredientsMarch 30, 2022
Vx-66157572-0719PowderBulk ingredientsMay 5, 2021
Vx-44557572-0717PowderBulk ingredientsAugust 14, 2020
Vx-80957572-0716PowderBulk ingredientsMarch 2, 2020
Crisaborole57572-0715PowderBulk ingredientsApril 19, 2018
Tenofovir alafenamide fumarate57572-0040PowderBulk ingredientsFebruary 29, 2016
Ledispavir57572-0036PowderBulk ingredientsMarch 24, 2014
Cobicistat57572-0035PowderBulk ingredientsOctober 1, 2012
Azelastine hydrochloride57572-0713PowderBulk ingredientsSeptember 28, 2007
Levetiracetam57572-0034PowderBulk ingredientsSeptember 28, 2007

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.